If an older patient undergoes general anesthesia, cardiac complications are possible. One urologist forgot that, to his regret. Dr. Y, age 57, is an experienced general urologist who practices at a ...

Non-muscle-invasive bladder cancer is labor intensive and costly to manage. Owing to long-term survival rates and life-long monitoring and treatment, it is the most expensive cancer to manage in ...

In a trial, Xpert® Bladder Cancer Monitor, a non-invasive urinary biomarker test, appeared suitable for guiding cystoscopy during monitoring of patients with NMIBC. Alternating between cystoscopy and ...

Bladder biopsy of normal-looking mucosa, as determined by cystoscopy, might not add clinical value in patients with positive voided-urine cytology after treatment of non-muscle-invasive bladder cancer ...

NEW ORLEANS -- Using a tool to classify patients' infection risk and providing education and systems-level changes in the urology department safely reduced prophylactic antibiotic use around ...

ORANGEBURG, N.Y., May 13, 2011 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI) announced today the introduction by Stryker Corporation ("Stryker") of the new line of EndoSheath Cystoscopy ...

Adding Bladder EpiCheck to cystoscopy for non-muscle invasive bladder cancer (NMIBC) surveillance and, if positive, performing biopsy under photodynamic diagnosis (PDD), significantly improved ...

Bladder cancer affects more than 86,000 people in the United States each year, according to the American Cancer Society, with the majority being over age 55. And while the disease can often be ...

MILAN, Italy--(BUSINESS WIRE)--Vision-Sciences, Inc. (Nasdaq: VSCI) announced the international introduction of its video cystoscopy platform at the 23 rd Annual European Association of Urology (EAU) ...

OSLO, Norway, March 24, 2025 /PRNewswire/ --Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces two abstract presentations at the 2025 European Association of Urology congress (EAU) in ...